Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area

키워드

참고문헌 (32)

1. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
2. Guo R, "Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma", Cancer, 125, pp.79~89 (2019)
3. Tendulkar RD, "Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy", J Clin Oncol, 34, pp.3648~3654 (2016)
4. Huang YQ, "Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer", J Clin Oncol, 34, pp.2157~2164 (2016)
5. Liang W, "Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer", J Clin Oncol, 33, pp.861~869 (2015)
6. Tang LQ, "Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma", J Natl Cancer Inst, 108, pp.djv291~ (2016)
7. Lu-Lu Zhang, "Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients", Cancer Research and Treatment, 50(4), pp.1084~1095 (2018), 대한암학회
8. Zeng Q, "Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area", Oncotarget, 7, pp.29708~29719 (2016)
9. Huang XD, "Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era : a bigdata, intelligence platform-based analysis", Radiother Oncol, 129, pp.389~395 (2018)
10. Ya-Nan Jin, "The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era", Cancer Research and Treatment, 51(1), pp.34~42 (2019), 대한암학회
11. "Using time dependent covariates and time dependent coefficients in the Cox model" (2014)[URL]
12. "rms: Regression Modeling Strategies" (2014)[URL]
13. "Package ‘compareC’" (2015)[URL]
14. Mao YP, "Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy", Chin J Cancer, 35, pp.103~ (2016)
15. Tang LL, "Validation of the 8th Edition of the UICC", AJCC staging system for nasopharyngeal carcinoma from endemic areas in the intensity-modulated radiotherapy era, 2017, pp.15, 913~919
16. Liang W, "Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment", Chin J Cancer, 35, pp.98~ (2016)
17. Chen YP, "Nasopharyngeal carcinoma", Lancet, 394, pp.64~80 (2019)
18. Sun X, "Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma : an analysis of survival and treatment toxicities", Radiother Oncol, 110, pp.398~403 (2014)
19. Lai SZ, "How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?", Int J Radiat Oncol Biol Phys, 80, pp.661~668 (2011)
20. Wu LR, "Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy : an analysis of 614 patients from a single center", Oral Oncol, 69, pp.26~32 (2017)
21. Yao JJ, "Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?", Ther Adv Med Oncol, 11, pp.1758835919833863~ (2019)
22. Chua DT, "Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma : a pooled data analysis of two phase III trials", J Clin Oncol, 23, pp.1118~1124 (2005)
23. Chang H, "Necessity of concurrent chemotherapy in N2-3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥ 3cycles followed by intensity-modulated radiotherapy", Cancer Med, 8, pp.2823~2831 (2019)
24. Zhang MX, "Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy : A 10-year experience with a large cohort and long follow-up", Eur J Cancer, 51, pp.2587~2595 (2015)
25. Lee AW, "Nasopharyngeal carcinoma : salvage of local recurrence", Oral Oncol, 48, pp.768~774 (2012)
26. Zhang B, "Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma", Clin Cancer Res, 23, pp.4259~4269 (2017)
27. Gu B, "Establishment and validation of a nomogram with intratumoral heterogeneity derived from(18)F-FDG PET", CT for predicting individual conditional risk of 5-year recurrence before initial treatment of nasopharyngeal carcinoma, 2020, pp.20, 37~
28. Peng G, "A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma", Radiother Oncol, 104, pp.286~293 (2012)
29. Au KH, "Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy(IMRT)in Hong Kong : a report of 3328 patients(HKNPCSG 1301 study)", Oral Oncol, 77, pp.16~21 (2018)
30. Sun Y, "Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system", BMC Cancer, 12, pp.68~ (2012)
31. 조원경, "Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients", Cancer Research and Treatment, 51(2), pp.603~610 (2019), 대한암학회
32. Jin YN, "Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma?", J Cancer, 8, pp.976~982 (2017)

관련 논문AI추천